Drug LitigationWas Your Infant Born with PPHN?

December 6, 2011

Tragically, a large and growing number of infants are born with persistent pulmonary hypertension (PPHN), a serious, potentially life-threatening pulmonary condition. For a PPHN baby, inordinately high pressure in the lung blood vessels prevents the child from getting sufficient oxygen into his or her bloodstream.

 

The causes of PPHN are many, but medical researchers have recently concluded that one significant contributing factor is whether the child’s mother took a SSRI antidepressant during pregnancy. Selective serotonin reuptake inhibitors (SSRIs), a common prescribed class of antidepressants that includes Prozac (fluoxetine) among others, have been found to increase the probability of delivering a PPHN baby by six times!

 

This research reveals a striking picture that’s markedly different from the one drug manufacturers portray with million dollar ad campaigns. Regardless of their benefits, SSRI drugs like Prozac (fluoxetine) pose considerable threats to pregnant women and their families. Unfortunately, too many women were ill-equipped to make an informed decision about whether to take Prozac during pregnancy – with sometimes catastrophic results.

 

The legal professionals at Nachawati Law Group are fighting back for victims of dangerous drugs like Prozac. If your child was born with PPHN as a result of your exposure to Prozac, you should contact us immediately! Your rights may have been violated; and you may have a viable cause of action against the drug manufacturers who made that injury possible. For a free consultation, call us at 1.866.545.8364 or email [email protected]

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy